Home›Companies›Biotech & Pharma›NeuraMedica

NeuraMedica Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 26, 2024·Suggest an edit

About NeuraMedica

NeuraMedica is a private company based in Oregon City, Oregon. It has reported $1,849,622 raised in three offerings on Form D since June 2018.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 26, 2023Jul 10, 2023amended Nov 26, 2024$709,622of $1.0M target13$54,586SAFE (Simple Agreement for Future Equity)Rule 506(b)Form D/A ↗2 earlier filings
Jan 28, 2021Feb 4, 2021$1,100,000fully sold5$220KEquityRule 506(b)Form D ↗
Jun 7, 2018Jun 22, 2018$40,000of $150K target2$20,000Simple Agreement for Future EquityRule 506(b)Form D ↗
Total, three offerings$1,849,622

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on NeuraMedica's Form D filed Nov 26, 2024.

MT
NR
Neil Roundy
Executive officer, director and promoter
RD
Rachel Dreilinger
Executive officer, director and promoter

Earlier filings also listed John Alleman (director, last listed Feb 2021) and Coni Rosati (director and promoter, last listed Jun 2018).

Sources

  1. SECNeuraMedica Inc. Form D/A, filed Dec 11, 2023
  2. SECNeuraMedica Inc. Form D, filed Jul 10, 2023
  3. SECNeuraMedica Inc. filing history